Motif ID: Klf16_Sp8
Z-value: 1.075
Transcription factors associated with Klf16_Sp8:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Klf16 | ENSMUSG00000035397.8 | Klf16 |
Sp8 | ENSMUSG00000048562.6 | Sp8 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Sp8 | mm10_v2_chr12_+_118846329_118846329 | 0.79 | 8.3e-09 | Click! |
Klf16 | mm10_v2_chr10_-_80577285_80577327 | -0.60 | 9.6e-05 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 28.7 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
3.4 | 13.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
3.3 | 9.9 | GO:0030421 | defecation(GO:0030421) |
2.8 | 11.4 | GO:0003360 | brainstem development(GO:0003360) |
2.4 | 2.4 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
2.4 | 7.1 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
2.3 | 11.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
2.0 | 2.0 | GO:0061386 | closure of optic fissure(GO:0061386) |
2.0 | 6.1 | GO:0060489 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.9 | 5.7 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
1.9 | 5.6 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
1.9 | 14.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.8 | 7.3 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
1.8 | 5.4 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
1.7 | 1.7 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
1.6 | 4.7 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
1.5 | 4.6 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
1.5 | 3.0 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.5 | 7.3 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.5 | 1.5 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
1.4 | 1.4 | GO:0048818 | positive regulation of hair follicle maturation(GO:0048818) |
1.4 | 5.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
1.4 | 4.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
1.4 | 4.1 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.4 | 5.4 | GO:0060032 | notochord regression(GO:0060032) |
1.3 | 4.0 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
1.3 | 5.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
1.3 | 3.9 | GO:0036166 | phenotypic switching(GO:0036166) |
1.3 | 7.5 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
1.2 | 3.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
1.2 | 3.6 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.2 | 3.6 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.2 | 4.8 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.2 | 5.9 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
1.2 | 3.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
1.2 | 3.5 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
1.2 | 4.7 | GO:0061743 | motor learning(GO:0061743) |
1.2 | 3.5 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
1.2 | 3.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.2 | 3.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
1.1 | 3.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.1 | 3.4 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
1.1 | 5.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
1.1 | 1.1 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
1.1 | 2.2 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.1 | 3.3 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
1.1 | 2.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
1.1 | 3.3 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
1.1 | 4.3 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
1.1 | 3.2 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
1.1 | 16.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.1 | 12.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.1 | 1.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.1 | 5.3 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
1.1 | 5.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
1.1 | 5.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.1 | 3.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
1.0 | 5.2 | GO:0032901 | positive regulation of neurotrophin production(GO:0032901) |
1.0 | 1.0 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
1.0 | 10.2 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
1.0 | 5.0 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
1.0 | 2.0 | GO:0030432 | peristalsis(GO:0030432) |
1.0 | 3.9 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
1.0 | 1.0 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.0 | 7.7 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
1.0 | 5.8 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
1.0 | 1.9 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.9 | 2.8 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.9 | 2.8 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.9 | 7.4 | GO:0046469 | platelet activating factor metabolic process(GO:0046469) |
0.9 | 3.7 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.9 | 9.2 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 2.8 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.9 | 8.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.9 | 5.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.9 | 8.1 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.9 | 3.6 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.9 | 1.8 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.9 | 0.9 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.8 | 2.5 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.8 | 3.4 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.8 | 0.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.8 | 3.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
0.8 | 5.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.8 | 1.7 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.8 | 1.7 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.8 | 3.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.8 | 3.3 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.8 | 6.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.8 | 5.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.8 | 8.1 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.8 | 2.4 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.8 | 0.8 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.8 | 0.8 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
0.8 | 0.8 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
0.8 | 1.6 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.8 | 2.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.8 | 10.2 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.8 | 2.3 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.8 | 0.8 | GO:0007135 | meiosis II(GO:0007135) |
0.8 | 16.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.8 | 7.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.8 | 1.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.8 | 2.3 | GO:1904170 | regulation of bleb assembly(GO:1904170) |
0.8 | 2.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.8 | 1.5 | GO:2000373 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.8 | 3.8 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.8 | 1.5 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
0.7 | 2.2 | GO:0014028 | notochord formation(GO:0014028) |
0.7 | 0.7 | GO:0097237 | cellular response to toxic substance(GO:0097237) |
0.7 | 2.2 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.7 | 2.2 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.7 | 2.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.7 | 2.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.7 | 0.7 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.7 | 0.7 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 2.2 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.7 | 2.2 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.7 | 0.7 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.7 | 6.4 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.7 | 5.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.7 | 1.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.7 | 2.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.7 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.7 | 2.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.7 | 8.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.7 | 4.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.7 | 6.3 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.7 | 4.2 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.7 | 2.1 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.7 | 2.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.7 | 3.5 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.7 | 2.8 | GO:0070269 | pyroptosis(GO:0070269) |
0.7 | 2.1 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
0.7 | 0.7 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
0.7 | 2.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.7 | 2.0 | GO:0003263 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.7 | 2.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.7 | 3.4 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 2.7 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
0.7 | 0.7 | GO:0045137 | development of primary sexual characteristics(GO:0045137) |
0.7 | 1.3 | GO:0072235 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) |
0.7 | 1.3 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.7 | 5.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.7 | 0.7 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.7 | 3.3 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.7 | 8.5 | GO:0001675 | acrosome assembly(GO:0001675) |
0.7 | 3.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.6 | 2.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.6 | 3.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.6 | 0.6 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.6 | 5.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.6 | 2.5 | GO:0015889 | cobalamin transport(GO:0015889) |
0.6 | 3.8 | GO:0044351 | macropinocytosis(GO:0044351) |
0.6 | 3.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.6 | 1.9 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.6 | 1.2 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.6 | 1.2 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.6 | 1.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.6 | 0.6 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.6 | 0.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.6 | 1.2 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.6 | 3.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.6 | 7.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.6 | 4.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.6 | 2.4 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.6 | 2.4 | GO:0046655 | glycine biosynthetic process(GO:0006545) folic acid metabolic process(GO:0046655) |
0.6 | 1.7 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.6 | 0.6 | GO:0010389 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) |
0.6 | 1.2 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.6 | 2.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.6 | 2.3 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.6 | 3.5 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.6 | 5.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.6 | 4.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.6 | 1.7 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.6 | 5.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.6 | 1.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
0.6 | 4.5 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.6 | 0.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.6 | 4.5 | GO:0048102 | autophagic cell death(GO:0048102) |
0.6 | 1.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.6 | 2.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.6 | 1.7 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.6 | 2.2 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.6 | 1.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.6 | 2.2 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
0.5 | 0.5 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 1.6 | GO:0051026 | chiasma assembly(GO:0051026) |
0.5 | 2.2 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.5 | 1.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.5 | 4.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 6.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.5 | 2.2 | GO:0072272 | proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
0.5 | 4.3 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.5 | 0.5 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 9.7 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.5 | 2.1 | GO:0030091 | protein repair(GO:0030091) |
0.5 | 2.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 5.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 3.7 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.5 | 1.6 | GO:0006116 | NADH oxidation(GO:0006116) |
0.5 | 2.1 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.5 | 2.1 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.5 | 5.7 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 3.6 | GO:2000380 | regulation of mesoderm development(GO:2000380) negative regulation of mesoderm development(GO:2000381) |
0.5 | 5.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.5 | 3.1 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 3.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.5 | 14.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.5 | 1.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.5 | 4.5 | GO:0048864 | stem cell development(GO:0048864) |
0.5 | 1.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.5 | 1.5 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.5 | 1.5 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
0.5 | 3.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.5 | 4.0 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.5 | 1.0 | GO:0045950 | negative regulation of mitotic recombination(GO:0045950) |
0.5 | 4.0 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
0.5 | 3.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.5 | 1.5 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.5 | 1.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.5 | 1.5 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.5 | 4.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 1.5 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.5 | 2.9 | GO:0000279 | M phase(GO:0000279) |
0.5 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.5 | 4.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.5 | 0.5 | GO:0048382 | mesendoderm development(GO:0048382) |
0.5 | 1.5 | GO:0043587 | tongue morphogenesis(GO:0043587) fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
0.5 | 1.9 | GO:0044838 | cell quiescence(GO:0044838) |
0.5 | 2.8 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.5 | 2.4 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 4.2 | GO:0072189 | ureter development(GO:0072189) |
0.5 | 3.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 8.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.5 | 2.8 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.5 | 2.3 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.5 | 1.4 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.5 | 0.5 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.5 | 1.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.5 | 1.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.5 | 2.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.5 | 4.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.5 | 1.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.5 | 0.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.5 | 1.4 | GO:0043586 | tongue development(GO:0043586) |
0.5 | 5.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.5 | 0.5 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.5 | 0.5 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.5 | 1.8 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.4 | 1.3 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 2.7 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.3 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.4 | 2.7 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.4 | 3.1 | GO:0048478 | replication fork protection(GO:0048478) |
0.4 | 4.0 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.4 | 1.7 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.4 | 2.2 | GO:0072431 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.4 | 3.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.4 | 17.8 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.4 | 0.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.4 | 4.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 3.9 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 2.1 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.4 | 2.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.4 | 4.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.4 | 0.4 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
0.4 | 0.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.4 | 2.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.4 | 0.8 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.4 | 4.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.4 | 1.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.4 | 2.9 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.4 | 0.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.4 | 1.6 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.4 | 1.2 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 0.4 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) |
0.4 | 2.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.4 | 0.4 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
0.4 | 3.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.4 | 1.2 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
0.4 | 1.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.4 | 1.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 0.8 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.4 | 0.4 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.4 | 1.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 1.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 0.4 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.4 | 1.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 3.2 | GO:0043584 | nose development(GO:0043584) |
0.4 | 0.8 | GO:1902566 | regulation of eosinophil activation(GO:1902566) |
0.4 | 1.2 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
0.4 | 0.8 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.4 | 5.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.4 | 3.5 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 0.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 0.8 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.4 | 2.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.4 | 3.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.4 | 2.3 | GO:0000052 | citrulline metabolic process(GO:0000052) |
0.4 | 0.4 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.4 | 1.1 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.4 | 0.8 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.4 | 1.9 | GO:0051697 | protein delipidation(GO:0051697) |
0.4 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.4 | 0.4 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.4 | 5.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.4 | 2.3 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.4 | 9.7 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.4 | 4.9 | GO:0051451 | myoblast migration(GO:0051451) |
0.4 | 0.7 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 0.4 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.4 | 0.4 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.4 | 7.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.4 | 1.5 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.4 | 1.1 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 4.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.4 | 1.1 | GO:0072217 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) negative regulation of metanephros development(GO:0072217) |
0.4 | 2.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.4 | 1.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.4 | 0.7 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 0.7 | GO:1990839 | response to endothelin(GO:1990839) |
0.4 | 2.5 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.4 | 0.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.4 | 3.6 | GO:0071435 | potassium ion export(GO:0071435) |
0.4 | 2.9 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.4 | 4.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.4 | 0.4 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.4 | 0.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.4 | 1.4 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.4 | 1.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.4 | 10.2 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.4 | 1.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.3 | 0.7 | GO:0015675 | nickel cation transport(GO:0015675) |
0.3 | 0.3 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.3 | 0.3 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.3 | 2.8 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 2.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.3 | 0.7 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.3 | 1.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.3 | 2.8 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 0.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 4.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.3 | 0.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 0.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 0.7 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.3 | 3.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.3 | 0.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 3.7 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.3 | 0.7 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.3 | 0.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.3 | 1.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.3 | 0.7 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 0.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.3 | 2.0 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.3 | 0.3 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
0.3 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 1.0 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.3 | 1.0 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 0.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.3 | 0.7 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.3 | 1.0 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.3 | 1.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.3 | 1.6 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.3 | 2.6 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.3 | 1.0 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.3 | 1.0 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.3 | 2.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 2.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 8.0 | GO:1902186 | regulation of viral release from host cell(GO:1902186) |
0.3 | 1.3 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.3 | 4.1 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 0.6 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.3 | 1.3 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 2.5 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.3 | 0.3 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.3 | 0.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 0.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 1.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 0.6 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 0.9 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.3 | 1.8 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 0.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 1.8 | GO:0090383 | phagosome acidification(GO:0090383) |
0.3 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.3 | 1.8 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 3.9 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.3 | 0.6 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.3 | 5.4 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.3 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.3 | 0.9 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.3 | 0.6 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.3 | 0.6 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
0.3 | 4.4 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.3 | 0.9 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.3 | 2.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 1.8 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.3 | 1.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.3 | 0.9 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.3 | 1.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 0.6 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.3 | 0.3 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.3 | 1.1 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.3 | 0.9 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 0.3 | GO:0032916 | positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.3 | 3.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.3 | 0.6 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) |
0.3 | 0.3 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.3 | 0.3 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
0.3 | 0.8 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.3 | 0.8 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.3 | 3.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.3 | 2.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.3 | 1.4 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.3 | 0.8 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 1.1 | GO:0015744 | succinate transport(GO:0015744) |
0.3 | 3.0 | GO:0090103 | cochlea morphogenesis(GO:0090103) |
0.3 | 0.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 2.2 | GO:0060736 | prostate gland growth(GO:0060736) |
0.3 | 0.5 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.3 | 0.5 | GO:1902946 | protein localization to early endosome(GO:1902946) |
0.3 | 0.3 | GO:0061357 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) positive regulation of Wnt protein secretion(GO:0061357) |
0.3 | 2.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.3 | 4.0 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.3 | 0.3 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.3 | 1.1 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.3 | 4.6 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.3 | 0.8 | GO:0002865 | negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) |
0.3 | 1.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.3 | 0.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.3 | 0.8 | GO:0045414 | regulation of interleukin-8 biosynthetic process(GO:0045414) |
0.3 | 0.8 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 1.6 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 0.5 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.3 | 9.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
0.3 | 0.8 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.3 | 0.8 | GO:1990748 | cellular detoxification(GO:1990748) |
0.3 | 0.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.3 | 1.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.3 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 0.5 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 0.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 8.9 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.3 | 1.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 0.5 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.2 | 1.7 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 2.0 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 2.5 | GO:0051307 | meiotic chromosome separation(GO:0051307) |
0.2 | 1.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 1.2 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.2 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.2 | 0.5 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 2.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 0.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.2 | 1.7 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.2 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 2.9 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 17.7 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.2 | 1.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.5 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 1.5 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.2 | 2.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 1.4 | GO:0014883 | regulation of skeletal muscle adaptation(GO:0014733) transition between fast and slow fiber(GO:0014883) skeletal muscle adaptation(GO:0043501) |
0.2 | 0.7 | GO:1903048 | regulation of acetylcholine-gated cation channel activity(GO:1903048) |
0.2 | 1.2 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.2 | 0.5 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 1.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.5 | GO:0072103 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.2 | 1.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.2 | 0.5 | GO:0042246 | tissue regeneration(GO:0042246) |
0.2 | 0.7 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.2 | 1.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.2 | 0.2 | GO:0060688 | regulation of morphogenesis of a branching structure(GO:0060688) |
0.2 | 0.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.2 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.2 | 1.4 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.2 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.2 | GO:0010273 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
0.2 | 1.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.9 | GO:0035094 | response to nicotine(GO:0035094) |
0.2 | 1.6 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.2 | 0.7 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.2 | 1.6 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 1.6 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.2 | 0.7 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
0.2 | 3.4 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.5 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 3.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.2 | 0.9 | GO:0030576 | Cajal body organization(GO:0030576) |
0.2 | 0.4 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.2 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.7 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
0.2 | 0.9 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 1.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.7 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.2 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 1.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.2 | 0.9 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 2.0 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 1.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.2 | 0.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.4 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.2 | 2.2 | GO:0033260 | nuclear DNA replication(GO:0033260) |
0.2 | 2.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.2 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.2 | 1.3 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 0.6 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 0.4 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.2 | 2.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 0.4 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.2 | 0.6 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.2 | 1.7 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.2 | 0.2 | GO:0010224 | response to UV-B(GO:0010224) |
0.2 | 1.7 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 1.7 | GO:0071802 | cellular response to muramyl dipeptide(GO:0071225) negative regulation of podosome assembly(GO:0071802) |
0.2 | 0.2 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.2 | 1.0 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.2 | 0.4 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 1.9 | GO:0014823 | response to activity(GO:0014823) |
0.2 | 1.0 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 0.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.2 | 0.6 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.2 | 0.2 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 2.4 | GO:0046697 | decidualization(GO:0046697) |
0.2 | 0.2 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.2 | 0.4 | GO:0045989 | positive regulation of striated muscle contraction(GO:0045989) |
0.2 | 0.4 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.6 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.2 | 0.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.2 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 1.0 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 1.6 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.2 | 1.0 | GO:0032369 | negative regulation of lipid transport(GO:0032369) |
0.2 | 0.6 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.2 | 1.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.2 | 1.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 2.3 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.2 | 0.2 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 0.9 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.2 | GO:1900117 | regulation of execution phase of apoptosis(GO:1900117) |
0.2 | 1.7 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.7 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.2 | 1.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 3.0 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 1.9 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.2 | 0.6 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 0.4 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.2 | 0.2 | GO:0043489 | RNA stabilization(GO:0043489) |
0.2 | 1.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 0.2 | GO:0042832 | response to protozoan(GO:0001562) defense response to protozoan(GO:0042832) |
0.2 | 0.2 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.2 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.2 | 0.5 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.2 | 0.2 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.2 | 0.4 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.2 | GO:0097168 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 1.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.7 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.4 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.2 | 0.2 | GO:0045410 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.2 | 0.4 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.9 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.9 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 1.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.2 | 0.2 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.2 | 0.3 | GO:0006507 | GPI anchor release(GO:0006507) |
0.2 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.8 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.3 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.2 | 0.5 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 0.2 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 1.1 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.7 | GO:0070836 | caveola assembly(GO:0070836) |
0.2 | 1.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.5 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.2 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.2 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.3 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.2 | 0.3 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.5 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.2 | 0.5 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.2 | 1.2 | GO:0007549 | dosage compensation(GO:0007549) |
0.2 | 1.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 0.6 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 0.2 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.2 | 0.5 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.2 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 1.1 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 1.4 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 1.8 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.2 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 0.6 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 0.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 3.6 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 0.6 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.2 | 0.2 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.1 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.4 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.3 | GO:0009636 | response to toxic substance(GO:0009636) |
0.1 | 0.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.1 | 0.1 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 1.0 | GO:0006534 | cysteine metabolic process(GO:0006534) |
0.1 | 1.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 4.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
0.1 | 1.0 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.1 | 0.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 2.3 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 0.6 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.1 | 1.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.3 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.1 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.1 | 0.6 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.1 | 0.6 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.1 | 0.4 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 1.0 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.3 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.4 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.1 | 2.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.1 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.1 | 0.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.1 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.7 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.1 | 0.1 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.6 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
0.1 | 1.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.4 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.3 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.1 | 1.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 0.1 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.5 | GO:0030825 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 3.3 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.1 | 1.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.1 | 0.5 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.0 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.9 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.1 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.1 | 1.3 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.1 | 0.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.1 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.1 | 0.4 | GO:1905155 | regulation of phagocytosis, engulfment(GO:0060099) positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 1.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.1 | 0.3 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.1 | 0.1 | GO:2001160 | histone H3-K79 methylation(GO:0034729) regulation of histone H3-K79 methylation(GO:2001160) |
0.1 | 0.3 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.5 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.1 | 0.1 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.1 | 3.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.1 | 0.7 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 1.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.1 | 1.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 1.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.5 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.4 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.6 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.1 | 0.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.1 | 0.5 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.6 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.1 | 1.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 1.7 | GO:0071281 | cellular response to iron ion(GO:0071281) |
0.1 | 0.6 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.4 | GO:2000105 | positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.1 | 0.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 1.5 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.1 | 0.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.1 | 0.1 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.5 | GO:0070922 | small RNA loading onto RISC(GO:0070922) |
0.1 | 0.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.1 | 0.2 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.1 | 0.4 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.1 | 0.5 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.1 | 0.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.1 | 0.1 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
0.1 | 0.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.1 | 0.6 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 0.2 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 1.5 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.1 | 0.5 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.4 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 1.3 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) |
0.1 | 0.7 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.1 | 1.6 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.1 | 0.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.1 | 2.5 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.9 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 2.1 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
0.1 | 0.1 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.1 | 1.1 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.1 | 0.9 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.7 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 0.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0060149 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
0.1 | 0.4 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.3 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
0.1 | 0.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.7 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 1.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.1 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.1 | 0.4 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.3 | GO:0001828 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.1 | 0.3 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 0.1 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.1 | 0.7 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.3 | GO:1902608 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.1 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.1 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.2 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.1 | 0.8 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.1 | 0.3 | GO:1903363 | negative regulation of cellular protein catabolic process(GO:1903363) |
0.1 | 1.0 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.1 | 0.3 | GO:0046135 | pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 2.7 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.3 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 1.3 | GO:0030901 | midbrain development(GO:0030901) |
0.1 | 0.7 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.1 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 1.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.7 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.1 | 0.7 | GO:0070193 | synaptonemal complex organization(GO:0070193) |
0.1 | 0.2 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.1 | 0.9 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.1 | 0.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 1.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.6 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.8 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.3 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.2 | GO:1900048 | positive regulation of blood coagulation(GO:0030194) positive regulation of hemostasis(GO:1900048) |
0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 1.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0010896 | negative regulation of sequestering of triglyceride(GO:0010891) regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.7 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 1.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.3 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.3 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.1 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.9 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 2.7 | GO:0032435 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
0.1 | 0.3 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 1.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.1 | 0.3 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 1.0 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.1 | 0.2 | GO:0033690 | positive regulation of osteoblast proliferation(GO:0033690) |
0.1 | 0.2 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.1 | 0.9 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.5 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.1 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.4 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.1 | 1.3 | GO:0031529 | ruffle organization(GO:0031529) |
0.1 | 0.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 1.0 | GO:0001843 | neural tube closure(GO:0001843) |
0.1 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 0.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.1 | 0.1 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.1 | 1.9 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.1 | 1.0 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.2 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) cell-cell adhesion involved in gastrulation(GO:0070586) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.1 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
0.1 | 0.7 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.6 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.1 | 0.3 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.1 | 0.2 | GO:0015808 | L-alanine transport(GO:0015808) |
0.1 | 1.6 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.1 | 0.1 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.1 | 0.5 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 3.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.6 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) |
0.1 | 0.2 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.5 | GO:0035090 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 1.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 1.1 | GO:0042407 | cristae formation(GO:0042407) |
0.1 | 0.3 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.1 | 1.2 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.1 | 0.4 | GO:0051189 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.1 | GO:1900673 | olefin metabolic process(GO:1900673) |
0.1 | 0.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.1 | 0.1 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.1 | 0.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.2 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.4 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.4 | GO:0016926 | protein desumoylation(GO:0016926) |
0.1 | 0.4 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 1.4 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 1.6 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.1 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.1 | 0.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.1 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 1.9 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.1 | 0.1 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.1 | 0.7 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.1 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.1 | 0.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:0030035 | microspike assembly(GO:0030035) |
0.1 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.1 | 0.1 | GO:0072203 | cell proliferation involved in metanephros development(GO:0072203) |
0.1 | 0.9 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.1 | 0.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.1 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.1 | 0.2 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.1 | 0.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.3 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.1 | 0.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.3 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 1.9 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.1 | 0.6 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.1 | GO:0017144 | drug metabolic process(GO:0017144) |
0.1 | 0.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.3 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.1 | 0.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.6 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 0.3 | GO:0098706 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.1 | 0.5 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.1 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.1 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
0.1 | 2.3 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 1.7 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.4 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.2 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.2 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.1 | 0.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.5 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.2 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.1 | 0.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 1.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.1 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.1 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.1 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 0.2 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.1 | GO:0071305 | cellular response to vitamin D(GO:0071305) |
0.1 | 0.8 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 3.7 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 0.2 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 0.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.3 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.0 | GO:0032506 | cytokinetic process(GO:0032506) |
0.0 | 0.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 0.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.1 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) icosanoid biosynthetic process(GO:0046456) prostanoid biosynthetic process(GO:0046457) fatty acid derivative biosynthetic process(GO:1901570) |
0.0 | 0.2 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.0 | 0.5 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.4 | GO:0031050 | dsRNA fragmentation(GO:0031050) production of small RNA involved in gene silencing by RNA(GO:0070918) |
0.0 | 1.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.8 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.0 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.0 | 0.1 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.0 | 0.2 | GO:0032608 | interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
0.0 | 1.7 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 0.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.1 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.7 | GO:0009208 | pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) |
0.0 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.2 | GO:0033151 | V(D)J recombination(GO:0033151) |
0.0 | 0.6 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.1 | GO:0006323 | DNA packaging(GO:0006323) |
0.0 | 0.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.0 | 0.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.0 | 0.0 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.2 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.0 | 0.8 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.2 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.0 | 0.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.1 | GO:0060964 | regulation of gene silencing by miRNA(GO:0060964) |
0.0 | 0.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.0 | 1.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
0.0 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:1901526 | positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.0 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0060135 | maternal process involved in female pregnancy(GO:0060135) |
0.0 | 0.1 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 0.1 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.0 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.0 | 0.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.1 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.0 | 0.1 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.0 | 0.1 | GO:1903028 | asymmetric Golgi ribbon formation(GO:0090164) regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
0.0 | 0.0 | GO:0035729 | cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.0 | 0.1 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.0 | 0.0 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.2 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.4 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
0.0 | 0.1 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.2 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.0 | 0.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.2 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.0 | 0.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.1 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 1.4 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.0 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 1.4 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.3 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.2 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.3 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.0 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:1903061 | regulation of protein lipidation(GO:1903059) positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:0032205 | negative regulation of telomere maintenance(GO:0032205) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.0 | 0.1 | GO:0035989 | tendon development(GO:0035989) |
0.0 | 0.2 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
0.0 | 0.2 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
0.0 | 0.4 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
0.0 | 1.5 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.4 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.1 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.1 | GO:0007320 | insemination(GO:0007320) |
0.0 | 0.3 | GO:0001947 | heart looping(GO:0001947) |
0.0 | 0.0 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.0 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
0.0 | 0.1 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.5 | GO:0060324 | face development(GO:0060324) |
0.0 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.0 | 0.3 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
0.0 | 0.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.0 | GO:0048793 | pronephros development(GO:0048793) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
0.0 | 0.0 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.0 | GO:0036006 | response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
0.0 | 0.1 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.0 | 0.0 | GO:0051784 | negative regulation of nuclear division(GO:0051784) |
0.0 | 0.1 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.0 | 0.1 | GO:0021684 | cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.0 | 0.1 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.0 | 0.0 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.0 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.0 | 0.2 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.0 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.0 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 0.1 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.0 | 0.1 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.0 | 0.1 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.0 | 0.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.0 | 0.2 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.0 | 0.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.0 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.0 | 0.6 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.3 | GO:0001836 | release of cytochrome c from mitochondria(GO:0001836) |
0.0 | 0.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:1904923 | regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) |
0.0 | 0.3 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.1 | GO:0006414 | translational elongation(GO:0006414) |
0.0 | 0.1 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.1 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.2 | GO:0031648 | protein destabilization(GO:0031648) |
0.0 | 0.1 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.1 | GO:0090101 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0090101) |
0.0 | 0.0 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.0 | 0.8 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.0 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.0 | 0.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.0 | 0.0 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.0 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.8 | 11.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
3.1 | 9.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
2.7 | 13.7 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.8 | 17.6 | GO:0000796 | condensin complex(GO:0000796) |
1.7 | 8.5 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.7 | 1.7 | GO:0042585 | germinal vesicle(GO:0042585) |
1.5 | 9.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
1.5 | 4.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
1.3 | 3.8 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.1 | 3.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
1.0 | 4.2 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
1.0 | 3.0 | GO:0071953 | elastic fiber(GO:0071953) |
1.0 | 6.9 | GO:0008278 | cohesin complex(GO:0008278) |
0.9 | 5.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.9 | 9.7 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.9 | 3.5 | GO:0090537 | CERF complex(GO:0090537) |
0.9 | 4.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.9 | 4.3 | GO:0044301 | climbing fiber(GO:0044301) |
0.8 | 2.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.8 | 16.4 | GO:0010369 | chromocenter(GO:0010369) |
0.8 | 3.2 | GO:0001940 | male pronucleus(GO:0001940) |
0.8 | 0.8 | GO:1902737 | dendritic filopodium(GO:1902737) |
0.8 | 2.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.8 | 0.8 | GO:0042581 | specific granule(GO:0042581) |
0.8 | 3.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.7 | 3.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.7 | 6.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.7 | 13.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.7 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.7 | 2.0 | GO:0035061 | interchromatin granule(GO:0035061) |
0.6 | 1.9 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.6 | 2.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.6 | 3.1 | GO:0005861 | troponin complex(GO:0005861) |
0.6 | 4.2 | GO:0001740 | Barr body(GO:0001740) |
0.6 | 3.5 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 2.3 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.6 | 5.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.6 | 1.7 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.6 | 5.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 7.8 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.5 | 10.4 | GO:0097470 | ribbon synapse(GO:0097470) |
0.5 | 4.3 | GO:0033269 | internode region of axon(GO:0033269) |
0.5 | 5.9 | GO:0016589 | NURF complex(GO:0016589) |
0.5 | 3.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 3.7 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 2.1 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.5 | 1.5 | GO:0001939 | female pronucleus(GO:0001939) |
0.5 | 2.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.5 | 2.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.5 | 1.9 | GO:0060187 | cell pole(GO:0060187) |
0.5 | 1.9 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.5 | 0.9 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.5 | 1.9 | GO:0061702 | inflammasome complex(GO:0061702) |
0.5 | 7.0 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.5 | 4.6 | GO:0090543 | Flemming body(GO:0090543) |
0.5 | 0.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 1.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.4 | 0.9 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.4 | 1.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.4 | 3.9 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.4 | 1.7 | GO:0032021 | NELF complex(GO:0032021) |
0.4 | 3.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 6.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 4.1 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 2.4 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.4 | 2.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.4 | 3.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 0.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.4 | 2.8 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.4 | 1.6 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.4 | 5.0 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
0.4 | 4.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.4 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.4 | 7.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.4 | 1.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 1.0 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.3 | 8.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.3 | 0.7 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 1.4 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.3 | 2.4 | GO:0043219 | lateral loop(GO:0043219) |
0.3 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 2.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 2.3 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.3 | 2.0 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 1.0 | GO:0035101 | FACT complex(GO:0035101) |
0.3 | 2.2 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 2.2 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 2.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 4.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.9 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 2.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 0.9 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.3 | 3.9 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.3 | 3.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.3 | 1.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 1.8 | GO:0098536 | deuterosome(GO:0098536) |
0.3 | 12.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 3.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.3 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 8.3 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.3 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.3 | 0.5 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.3 | 1.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 1.4 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.3 | 2.4 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 3.7 | GO:0031011 | Ino80 complex(GO:0031011) |
0.3 | 4.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.3 | 5.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 14.8 | GO:0005844 | polysome(GO:0005844) |
0.3 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 1.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.3 | 1.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.3 | 1.0 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.3 | 1.5 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.2 | 0.7 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.2 | 2.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 0.5 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 4.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 2.4 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.2 | 0.5 | GO:0044305 | calyx of Held(GO:0044305) |
0.2 | 1.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 1.4 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.2 | 14.0 | GO:0016459 | myosin complex(GO:0016459) |
0.2 | 0.5 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.2 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 1.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 16.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.2 | 1.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 0.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 3.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 6.1 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 3.1 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.2 | 1.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 3.1 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.2 | 0.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.2 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 1.5 | GO:0031415 | NatA complex(GO:0031415) |
0.2 | 0.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.2 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.2 | 5.2 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.2 | 1.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 6.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.2 | 1.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.2 | 13.3 | GO:0005657 | replication fork(GO:0005657) |
0.2 | 1.1 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 0.6 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.2 | 4.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 2.9 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 3.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.2 | 1.4 | GO:0045120 | pronucleus(GO:0045120) |
0.2 | 1.8 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.6 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
0.2 | 2.8 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.2 | 2.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 0.8 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.2 | 2.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.2 | 74.7 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.9 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 3.2 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 10.0 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 0.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.2 | 1.7 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 0.7 | GO:0031012 | extracellular matrix(GO:0031012) |
0.2 | 13.7 | GO:0005814 | centriole(GO:0005814) |
0.2 | 1.9 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 1.8 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 2.8 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.7 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.2 | 2.5 | GO:0001741 | XY body(GO:0001741) |
0.2 | 0.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 1.0 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 1.6 | GO:0000502 | proteasome complex(GO:0000502) |
0.2 | 3.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 2.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 1.0 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.9 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.2 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 2.0 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 1.7 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 5.6 | GO:0002102 | podosome(GO:0002102) |
0.2 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.2 | 0.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 0.6 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 0.4 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 0.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 4.8 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.1 | 1.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 1.4 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 2.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 7.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.1 | 2.3 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.6 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 1.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 0.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 3.2 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 4.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.4 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.7 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 1.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 0.4 | GO:0030934 | collagen type XII trimer(GO:0005595) anchoring collagen complex(GO:0030934) |
0.1 | 0.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.6 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 31.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 1.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.8 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 2.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 2.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 0.8 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.9 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 2.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 1.3 | GO:0043218 | compact myelin(GO:0043218) |
0.1 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 0.6 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.9 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 1.7 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 1.3 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.3 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.1 | 0.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 0.3 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 2.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 0.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.3 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 1.0 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 2.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.1 | 0.2 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 0.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 1.0 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 1.1 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 0.2 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 1.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 0.4 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.3 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 3.1 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.2 | GO:0071920 | cleavage body(GO:0071920) |
0.1 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.1 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 0.6 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.1 | 1.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.1 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.2 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.1 | 0.4 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.1 | 1.7 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 1.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 3.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 1.1 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 3.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.1 | 3.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.2 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.9 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 12.5 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 0.5 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.2 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.0 | 0.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.9 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.0 | 0.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 0.9 | GO:0030286 | dynein complex(GO:0030286) |
0.0 | 6.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.3 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.0 | 0.4 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.3 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.1 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.3 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 4.0 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.8 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 5.9 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 3.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.0 | 1.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.9 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 50.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.1 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 0.3 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 3.0 | GO:0005813 | centrosome(GO:0005813) |
0.0 | 0.0 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 1.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.1 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.2 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.0 | 46.1 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.0 | 0.0 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.3 | 4.7 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
2.3 | 9.2 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
2.0 | 6.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.6 | 4.9 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.6 | 9.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.5 | 4.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.4 | 6.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.3 | 10.6 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.3 | 3.9 | GO:0035939 | microsatellite binding(GO:0035939) |
1.3 | 3.9 | GO:0033680 | ATP-dependent DNA/RNA helicase activity(GO:0033680) |
1.3 | 6.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.3 | 6.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
1.2 | 17.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.2 | 3.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.1 | 6.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
1.1 | 3.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
1.1 | 3.2 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.0 | 6.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.0 | 11.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.0 | 4.1 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
1.0 | 4.1 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.0 | 4.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 4.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.0 | 4.0 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.9 | 3.8 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.9 | 4.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.9 | 2.7 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.9 | 0.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.9 | 2.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.9 | 3.6 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.9 | 2.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.8 | 7.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.8 | 3.3 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.8 | 4.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.8 | 7.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.8 | 4.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.8 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.8 | 3.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.8 | 0.8 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.8 | 2.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.8 | 2.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.8 | 6.9 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.8 | 14.3 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.8 | 2.3 | GO:0051870 | methotrexate binding(GO:0051870) |
0.7 | 2.9 | GO:1990254 | keratin filament binding(GO:1990254) |
0.7 | 4.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.7 | 0.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.7 | 2.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.7 | 2.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.7 | 2.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.7 | 0.7 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.7 | 2.7 | GO:0008142 | oxysterol binding(GO:0008142) |
0.7 | 2.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.6 | 3.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.6 | 2.6 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.6 | 2.5 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.6 | 13.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.6 | 3.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 6.2 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.6 | 2.5 | GO:0042806 | fucose binding(GO:0042806) |
0.6 | 3.7 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.6 | 3.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.6 | 1.8 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.6 | 2.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.6 | 0.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.6 | 1.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.6 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 1.7 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.6 | 3.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.6 | 23.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 4.6 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.6 | 10.7 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 2.8 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.5 | 1.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.5 | 4.3 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.5 | 1.6 | GO:0031208 | POZ domain binding(GO:0031208) |
0.5 | 1.0 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 1.6 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 1.6 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 2.6 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.5 | 4.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 2.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.5 | 3.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.5 | 1.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.5 | 4.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.5 | 1.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.5 | 1.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.5 | 1.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.5 | 1.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.5 | 1.9 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.5 | 2.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.5 | 6.1 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.5 | 12.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.5 | 5.0 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.5 | 22.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.5 | 1.4 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.4 | 3.1 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.4 | 15.2 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 2.7 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.4 | 0.9 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 2.6 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.4 | 3.0 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.4 | 2.1 | GO:1904047 | S-adenosyl-L-methionine binding(GO:1904047) |
0.4 | 1.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.4 | 5.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.4 | 1.7 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.4 | 2.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.4 | 5.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.4 | 1.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 3.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 2.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 2.4 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 2.4 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 1.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 2.0 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.4 | 2.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.4 | 1.5 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.4 | 5.4 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 2.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.4 | 5.3 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.4 | 3.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 2.6 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
0.4 | 1.1 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.4 | 2.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.4 | 1.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.4 | 4.7 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.4 | 2.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.1 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
0.4 | 10.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.3 | 1.7 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.3 | 1.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.3 | 31.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.3 | 3.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.3 | 1.7 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 1.0 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 1.3 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.3 | 2.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 1.0 | GO:0042936 | dipeptide transporter activity(GO:0042936) |
0.3 | 2.6 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 3.2 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.3 | 2.6 | GO:0030911 | TPR domain binding(GO:0030911) |
0.3 | 6.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.3 | 9.1 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.3 | 1.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 0.3 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.3 | 0.9 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.3 | 2.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.3 | 1.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 5.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 3.3 | GO:0008430 | selenium binding(GO:0008430) |
0.3 | 0.9 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.3 | 1.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.3 | 2.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 1.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 5.0 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.3 | 1.7 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.3 | 3.7 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.3 | 1.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 1.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.3 | 2.5 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.3 | 0.8 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.3 | 0.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.3 | 0.8 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.3 | 5.3 | GO:0070840 | dynein complex binding(GO:0070840) |
0.3 | 1.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 1.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.3 | 0.8 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.3 | 0.8 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.3 | 4.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.3 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 0.8 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.3 | 2.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.3 | 0.8 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.3 | 1.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 3.3 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 1.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.3 | 1.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 18.7 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.2 | 0.7 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.2 | 1.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 1.0 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.2 | 1.0 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.2 | 17.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.2 | 1.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.7 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.2 | 0.7 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
0.2 | 6.0 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 0.7 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.5 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 14.6 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.2 | 1.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.2 | 10.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.2 | 0.7 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.2 | 1.6 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.2 | 0.2 | GO:0003681 | bent DNA binding(GO:0003681) |
0.2 | 0.7 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.2 | 5.6 | GO:0070888 | E-box binding(GO:0070888) |
0.2 | 0.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 0.9 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.2 | 0.7 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
0.2 | 0.9 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 1.6 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 1.1 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 2.0 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 1.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 0.7 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
0.2 | 0.7 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.2 | 0.9 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 2.9 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.2 | 0.7 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.2 | 1.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.2 | 1.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 3.5 | GO:0051861 | glycolipid binding(GO:0051861) |
0.2 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 1.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 0.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 26.5 | GO:0001047 | core promoter binding(GO:0001047) |
0.2 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 1.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 2.8 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.2 | 1.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.2 | 3.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.2 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.1 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 0.6 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.2 | 2.9 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 1.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 2.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.2 | 1.2 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 0.8 | GO:0070976 | TIR domain binding(GO:0070976) |
0.2 | 1.6 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.2 | 1.4 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.2 | 0.8 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
0.2 | 0.6 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.2 | 2.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 3.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 5.3 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 3.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 0.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.2 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.4 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.7 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 0.6 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.2 | 34.3 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.2 | 4.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 0.4 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.2 | 0.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.2 | 27.8 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 11.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.7 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
0.2 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.7 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.2 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.2 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.2 | 1.1 | GO:0043176 | amine binding(GO:0043176) |
0.2 | 1.6 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
0.2 | 0.8 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 0.3 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 2.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 2.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.5 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.2 | 1.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.2 | 1.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.2 | 5.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 2.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 0.6 | GO:0034041 | lipid-transporting ATPase activity(GO:0034040) sterol-transporting ATPase activity(GO:0034041) |
0.2 | 2.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.3 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.4 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.1 | 2.5 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.1 | 0.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.1 | 1.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.1 | 27.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 1.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 1.9 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 1.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 1.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 2.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 1.5 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.1 | 0.8 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 3.0 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.1 | 1.2 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.1 | 0.4 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 0.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.6 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.4 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 1.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.1 | 0.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 2.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 1.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 9.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.6 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 1.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 0.6 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.1 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 2.0 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.4 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.1 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.1 | 0.3 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.3 | GO:0005118 | sevenless binding(GO:0005118) |
0.1 | 1.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.2 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.1 | 0.7 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 0.9 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 2.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.6 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.1 | 0.7 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.8 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.4 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.2 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 1.5 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.7 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.7 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.2 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.1 | 0.9 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 2.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 11.2 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 42.9 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.1 | 0.4 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.7 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 14.9 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 1.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.0 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.3 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.7 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 2.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 2.0 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.3 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.1 | 1.0 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 0.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.6 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 0.7 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.1 | 2.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 0.3 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.1 | 0.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.1 | 1.4 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.1 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.1 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.3 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.4 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 3.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.1 | 0.1 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.1 | 0.5 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.1 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.1 | 0.2 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.1 | 1.0 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.1 | 0.2 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 2.3 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.1 | 0.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.9 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 0.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.1 | 0.2 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 1.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 0.1 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.2 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.1 | 0.8 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.1 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.1 | 0.2 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.4 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.1 | 0.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.1 | 0.3 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.1 | 0.3 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 1.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 0.2 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.5 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.1 | 2.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.1 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 1.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.3 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.1 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 1.7 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 1.7 | GO:0000975 | regulatory region DNA binding(GO:0000975) transcription regulatory region DNA binding(GO:0044212) |
0.1 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.1 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 32.7 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 0.2 | GO:0070736 | protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) |
0.1 | 0.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.5 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.2 | GO:0055100 | adiponectin binding(GO:0055100) |
0.1 | 0.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 0.2 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
0.1 | 0.2 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.0 | 0.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.0 | 0.4 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 0.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.2 | GO:0050436 | microfibril binding(GO:0050436) |
0.0 | 1.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.0 | 0.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 1.0 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.0 | 0.3 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.2 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 0.1 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.0 | 0.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 1.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.2 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.3 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.0 | 0.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.1 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 1.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.1 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 1.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 0.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 1.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.0 | 1.3 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.8 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.2 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.1 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
0.0 | 0.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 2.1 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.1 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
0.0 | 0.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 1.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 23.4 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.0 | 46.8 | PID_AURORA_B_PATHWAY | Aurora B signaling |
0.8 | 0.8 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.7 | 0.7 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
0.7 | 6.0 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.6 | 32.7 | PID_PLK1_PATHWAY | PLK1 signaling events |
0.5 | 9.8 | ST_STAT3_PATHWAY | STAT3 Pathway |
0.5 | 0.9 | PID_IL3_PATHWAY | IL3-mediated signaling events |
0.4 | 1.2 | ST_ADRENERGIC | Adrenergic Pathway |
0.4 | 0.4 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 1.9 | PID_IL5_PATHWAY | IL5-mediated signaling events |
0.4 | 16.0 | PID_INTEGRIN_A4B1_PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 19.8 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.3 | 0.3 | PID_CD40_PATHWAY | CD40/CD40L signaling |
0.3 | 13.6 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.3 | 8.6 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
0.3 | 17.2 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.3 | 8.3 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.3 | 12.9 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 1.1 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
0.3 | 22.1 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.3 | 2.9 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.3 | 5.6 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 4.9 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.2 | 2.2 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 6.9 | PID_IGF1_PATHWAY | IGF1 pathway |
0.2 | 6.6 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.2 | 11.7 | PID_E2F_PATHWAY | E2F transcription factor network |
0.2 | 1.9 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 1.4 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.2 | 6.1 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 5.9 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.2 | 1.6 | PID_HDAC_CLASSII_PATHWAY | Signaling events mediated by HDAC Class II |
0.2 | 1.0 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.2 | 5.5 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.2 | 1.4 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.2 | 3.8 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 0.9 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.2 | 1.4 | PID_NEPHRIN_NEPH1_PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 6.4 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.2 | 6.8 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
0.2 | 1.6 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 7.8 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 2.3 | PID_AURORA_A_PATHWAY | Aurora A signaling |
0.2 | 0.8 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 4.7 | PID_RHOA_PATHWAY | RhoA signaling pathway |
0.2 | 9.5 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
0.2 | 0.5 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 0.9 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 4.6 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.1 | 0.6 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 0.9 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.1 | 3.1 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 5.0 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
0.1 | 4.5 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.4 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.1 | 3.6 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
0.1 | 1.7 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.7 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.1 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 2.7 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.1 | 2.8 | PID_P73PATHWAY | p73 transcription factor network |
0.1 | 3.4 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.1 | 1.2 | PID_MYC_PATHWAY | C-MYC pathway |
0.1 | 2.8 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.1 | 1.2 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
0.1 | 4.7 | PID_NOTCH_PATHWAY | Notch signaling pathway |
0.1 | 1.6 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
0.1 | 0.3 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
0.1 | 0.2 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.1 | 2.0 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.1 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 2.3 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
0.1 | 0.1 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
0.1 | 0.4 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.2 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
0.1 | 0.3 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
0.1 | 0.8 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
0.1 | 1.2 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
0.1 | 0.2 | PID_IL23_PATHWAY | IL23-mediated signaling events |
0.1 | 1.4 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.1 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 0.7 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.1 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 1.8 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.0 | 0.6 | PID_ATR_PATHWAY | ATR signaling pathway |
0.0 | 0.6 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.5 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
0.0 | 0.5 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.4 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.1 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 1.3 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.3 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.4 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.0 | 0.3 | NABA_CORE_MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.7 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.9 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.4 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
0.0 | 0.0 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.0 | 0.6 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.2 | PID_FOXO_PATHWAY | FoxO family signaling |
0.0 | 0.4 | ST_FAS_SIGNALING_PATHWAY | Fas Signaling Pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 18.8 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.9 | 3.6 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.8 | 1.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.7 | 9.8 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.7 | 20.3 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.6 | 16.9 | REACTOME_KINESINS | Genes involved in Kinesins |
0.6 | 4.9 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.6 | 10.4 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.6 | 7.2 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 9.6 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
0.6 | 1.2 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 1.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.6 | 31.3 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.6 | 19.7 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.5 | 4.4 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.5 | 4.0 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.5 | 9.8 | REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.4 | 7.6 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.4 | 1.3 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 8.3 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 4.6 | REACTOME_RECEPTOR_LIGAND_BINDING_INITIATES_THE_SECOND_PROTEOLYTIC_CLEAVAGE_OF_NOTCH_RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 10.7 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.4 | 10.5 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
0.4 | 2.2 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.4 | 30.5 | REACTOME_MITOTIC_PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.4 | 4.0 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 2.9 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 7.4 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.3 | 5.4 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.3 | 0.3 | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 7.0 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
0.3 | 5.5 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 0.3 | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.3 | 1.4 | REACTOME_PACKAGING_OF_TELOMERE_ENDS | Genes involved in Packaging Of Telomere Ends |
0.3 | 0.5 | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | Genes involved in G-protein beta:gamma signalling |
0.3 | 4.4 | REACTOME_MEIOTIC_RECOMBINATION | Genes involved in Meiotic Recombination |
0.3 | 4.7 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.3 | 3.1 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 2.7 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 2.9 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 5.4 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 6.7 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.2 | 4.6 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 2.2 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 6.7 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 3.7 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 4.1 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 5.3 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
0.2 | 0.6 | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 0.4 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 1.2 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 3.2 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.2 | 2.0 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 4.1 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 2.7 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.2 | 1.7 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.5 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 0.4 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.2 | 4.1 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 5.4 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 1.1 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 0.3 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.7 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 0.7 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 1.4 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
0.2 | 1.5 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.2 | 7.0 | REACTOME_MRNA_3_END_PROCESSING | Genes involved in mRNA 3'-end processing |
0.2 | 36.2 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 1.4 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 3.8 | REACTOME_RNA_POL_I_TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 6.4 | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.2 | 0.2 | REACTOME_GPCR_LIGAND_BINDING | Genes involved in GPCR ligand binding |
0.1 | 1.3 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 3.7 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 4.3 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 1.1 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.9 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.2 | REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.6 | REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 1.4 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 0.3 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.8 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 3.1 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 7.9 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
0.1 | 0.7 | REACTOME_LIPOPROTEIN_METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 1.3 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.2 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 3.8 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.0 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 0.8 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.7 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.1 | 2.2 | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.1 | 0.2 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.1 | 2.1 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 0.7 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 2.6 | REACTOME_RNA_POL_III_TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 0.1 | REACTOME_DOWNSTREAM_TCR_SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.5 | REACTOME_P2Y_RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.4 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.6 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.1 | REACTOME_BASE_EXCISION_REPAIR | Genes involved in Base Excision Repair |
0.1 | 0.2 | REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.9 | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.1 | 0.6 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.1 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.3 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 1.7 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 4.2 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.9 | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.0 | 3.7 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.4 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
0.0 | 0.6 | REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.0 | 1.4 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.0 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.7 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 1.4 | REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.0 | 1.2 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 1.1 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 1.9 | REACTOME_MITOTIC_G2_G2_M_PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.2 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.3 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.4 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.4 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.2 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.2 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.5 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.1 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.2 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.1 | REACTOME_SIGNALING_BY_WNT | Genes involved in Signaling by Wnt |
0.0 | 0.9 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.2 | REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE | Genes involved in Early Phase of HIV Life Cycle |
0.0 | 0.2 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.1 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
0.0 | 0.1 | REACTOME_IL_RECEPTOR_SHC_SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.0 | 0.5 | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.7 | REACTOME_3_UTR_MEDIATED_TRANSLATIONAL_REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.0 | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR1 ligand binding and activation |